Search Results 871-880 of 13767 for Assay

  1. Pharmacogenomics: Your Own Prescription - Mayo Clinic

    Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...

  2. Matthew J. Schellenberg, Ph.D. - Mayo Clinic Faculty Profiles

    In vitro assays to evaluate repair capacity of tumors. Dr. Schellenberg uses the latest techniques in recombinant protein expression and biological ...

  3. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Known PD-L1 tumor status as determined by an IHC assay performed by a central laboratory on previously obtained archival tumor tissue or tissue obtained from a ...

  4. Clinical Trials - The PEERLESS II Study

    ... assay used c. Respiratory: i. O2 saturation < 90% on room air ii. Supplemental O2 requirement ≥ 4 L/min iii. Respiratory rate ≥ 20 breaths/min iv. mMRC ...

  5. Steven N. Hart, Ph.D. - Mayo Clinic Faculty Profiles

    ... assays into clinical tests. Cancer genomics. Dr. Hart works toward integrated next-generation sequencing data analysis of multiple genomic features, such as ...

  6. Division of Anatomic Pathology - Clinical Trials

    To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr. Signature + for fingerstick INR. To familiarize the ...

  7. Study to Evaluate the Effectiveness and Safety of Remdesivir in Participants with Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 - Mayo Clinic

    ... assay (e.g., Nucleic Acid Amplification Test [NAAT] and antigen tests) in any respiratory specimen. Hospitalized for COVID-19. Age ≥ 12 years and weighing ...

  8. Ductal Carcinoma In Situ Clinical Trials - Mayo Clinic Research

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

  9. Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Measurable disease defined by any of following: Serum M-protein > 1 g/dL; Urine M-protein > 200 mg/24h; Serum free light chain (FLC) assay: involved FLC ...

  10. Thyroid Cancer Clinical Trials - Mayo Clinic Research

    5) are safe for people with specific delta-like protein 3-expressing cancers. cfDNA Assay ... assays to detect cancer early in blood. The purpose of this ...